Fractyl's oral GLP-1 gene therapy just got EMA green light, thoughts?

Posted by tiredmira in Research & News - 1 points, 0 comments.

So this actually showed up on my radar this week and I can't stop thinking about it. Fractyl's oral GLP-1 gene therapy got the EMA green light, which feels like a pretty big deal for anyone tracking the peptide space.

My honest take? It's promising but I'm not ready to call it a win yet. The idea of replacing daily injections with a one-time oral dose sounds almost too clean. For me the appeal is obvious, I hate pinning and the adherence fatigue on weekly shots is real, I already see it in friends who started strong and now skip weeks.

But gene therapy is not a peptide. It's a whole different risk profile and the long term data just isn't there. Curious how others are framing it. Is this the thing that finally pushes GLP-1 access mainstream, or are we getting excited over Phase 2 vibes dressed up as a regulatory milestone?

Would love to hear from anyone actually following Fractyl's trial design more closely than me. What am I missing?

Community discussion - research and educational context only. Not medical advice.